(Q38324837)

2 September 2017

title

New synthetic heparin mimetics able to inhibit thrombin and factor Xa. (English)

1 reference

2 September 2017

1 reference

Petitou M

1

1 reference

2 September 2017

Duchaussoy P

2

1 reference

2 September 2017

Driguez PA

3

1 reference

2 September 2017

Hérault JP

4

1 reference

2 September 2017

Lormeau JC

5

1 reference

2 September 2017

Herbert JM

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Bioorganic & Medicinal Chemistry Letters

2 September 2017

published in

1 reference

2 September 2017

volume

9

1 reference

2 September 2017

issue

8

1 reference

2 September 2017

page(s)

1155-1160

1 reference

Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Structural studies on a biologically active hexasaccharide obtained from heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Further characterization of the antithrombin-binding sequence in heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Regulation of thrombin activity by antithrombin and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

First Synthetic Carbohydrates with the Full Anticoagulant Properties of Heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

The clot thickens: clues provided by thrombin structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Vinyl glycosides in oligosaccharide synthesis (part 1): A new latent-active glycosylation strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Vinyl Glycosides in Oligosaccharide Synthesis. 2. The Use of Allyl and Vinyl Glycosides in Oligosaccharide Synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900155-9

7 January 2021

10.1016/S0960-894X(99)00155-9

Identifiers

DOI

1 reference

2 September 2017

1 reference